PTEN and neoplasm: Induction or oncogeneic activation of PD-L1 in non ‘inflamed’ tumours occurs through alternative pathways such as loss of PTEN or copy gain / amplification of CD274/PDL1 locus (Ch 9p24.1)[10, 15].